Can you have PCOS without ovarian cysts?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
Yes. PCOS can be diagnosed with no ovarian finding at all, because polycystic ovarian morphology is only one of three Rotterdam criteria and only two are required. The structures counted on ultrasound are not cysts, they are small immature follicles. Irregular cycles plus high androgens is enough to diagnose PCOS in an adult.
You can have PCOS with completely normal-looking ovaries. Polycystic ovarian morphology is one of the three Rotterdam criteria, and a diagnosis needs any two. A woman with irregular cycles and hyperandrogenism meets the criteria without an ultrasound being done. The 2023 International Evidence-based Guideline states directly that imaging is not required when those two features are already present.
The follicles counted on ultrasound are not cysts
What a sonographer counts in PCOS are antral follicles, the small fluid-filled sacs that every ovary contains and that hold immature eggs. They are two to nine millimetres across and they are supposed to be there. In PCOS more of them accumulate because ovulation is not happening reliably, so they queue rather than mature. A true ovarian cyst is a different structure, usually larger, often single, and not part of the PCOS definition at all.
The threshold that defines polycystic ovaries
For adults, the 2023 guideline sets polycystic ovarian morphology at 20 or more follicles in at least one ovary on a good quality transvaginal scan. Where imaging quality is limited, an ovarian volume of 10 mL or more can be used. That threshold rose over the years as ultrasound resolution improved, which is one reason older reports calling ovaries polycystic at 12 follicles do not carry the same meaning today.
You can also have polycystic ovaries without PCOS
The reverse mistake is more common than the one people worry about. Polycystic-looking ovaries are found in many young women with regular ovulatory cycles and no androgen excess, and that finding on its own is not PCOS. The 2023 guideline recommends against using ultrasound or AMH for diagnosis in adolescents at all, because normal puberty produces the same appearance. An incidental report of polycystic ovaries in a woman with regular periods and normal androgens needs no treatment.
Why the name changed in 2026
In May 2026 an international consensus led by Monash University, involving more than 56 patient and professional organisations and over 22,000 survey responses, renamed the condition polyendocrine metabolic ovarian syndrome, or PMOS. Part of the stated rationale was that the old name misled people into thinking the condition is about abnormal ovarian cysts, which it is not. The diagnostic criteria did not change, and the new name will be fully implemented in the next guideline update.
If your only abnormal result is an ultrasound report, ask two questions before accepting a PCOS label: are my cycles irregular by the guideline definition, and do I have hyperandrogenism on examination or on a mass spectrometry testosterone. Without one of those, an ovarian appearance alone does not make the diagnosis.
The clinical detail
Follicle number per ovary of 20 or more in at least one ovary is the adult threshold in the 2023 guideline, replacing the older 12-follicle Rotterdam figure, and it assumes a transducer frequency of at least 8 MHz. Where image quality prevents an accurate count, ovarian volume of 10 mL or more, or follicle number per cross section of 10 or more, is acceptable.
Serum AMH may substitute for ultrasound in adults using population and assay specific cut-offs, but performing both tests is discouraged because it inflates diagnosis. AMH is not valid in adolescents, in women on a combined oral contraceptive pill, or in the presence of significant ovarian surgery. Prevalence of PCOS is 10 to 13 per cent globally by Rotterdam criteria, so over-diagnosis at population scale is a real cost.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- International Evidence-based Guideline for the Assessment and Management of PCOS, 2023 summary. Monash University Centre for Health Research and Implementation
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism. PMID 37580314
- PCOS is Now PMOS: Understanding the Name Change. American Society for Reproductive Medicine
- Polycystic Ovary Syndrome. MedlinePlus, National Library of Medicine
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.